BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36527436)

  • 21. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of adjuvant radiotherapy in locally advanced T4 mandible squamous cell carcinoma in the N0 patient: a single centre experience.
    Lee CW; Jenkins GW; Lee-Warder L; Kennedy M; Iqbal MS; Adams J
    Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1251-1256. PubMed ID: 35090786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
    Mohan S; Pai SI; Bhattacharyya N
    Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
    Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
    Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.
    Kreppel M; Drebber U; Eich HT; Dreiseidler T; Zöller JE; Müller RP; Scheer M
    Strahlenther Onkol; 2011 Sep; 187(9):555-60. PubMed ID: 21424306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma.
    Gore SM; Crombie AK; Batstone MD; Clark JR
    Head Neck; 2015 Apr; 37(4):518-23. PubMed ID: 24532246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative hypoalbuminemia as a risk factor for surgical site infection after oral cancer surgery.
    Lee JI; Kwon M; Roh JL; Choi JW; Choi SH; Nam SY; Kim SY
    Oral Dis; 2015 Mar; 21(2):178-84. PubMed ID: 24605906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenging the Requirement to Treat the Contralateral Neck in Cases With >4 mm Tumor Thickness in Patients Receiving Postoperative Radiation Therapy for Squamous Cell Carcinoma of the Oral Tongue or Floor of Mouth.
    O'steen L; Amdur RJ; Morris CG; Hitchcock KE; Mendenhall WM
    Am J Clin Oncol; 2019 Jan; 42(1):89-91. PubMed ID: 30234502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Factors Are Associated With Regional Recurrence After Operative Treatment of Oral Squamous Cell Carcinoma?
    Troeltzsch M; Haidari S; Boser S; Troeltzsch M; Probst FA; Ehrenfeld M; Otto S
    J Oral Maxillofac Surg; 2018 Dec; 76(12):2650-2659. PubMed ID: 30098956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult Comorbidity Evaluation-27 as a predictor of postoperative complications, two-year mortality, duration of hospital stay, and readmission within 30 days in patients with squamous cell carcinoma of the head and neck.
    Milne S; Parmar J; Ong TK
    Br J Oral Maxillofac Surg; 2019 Apr; 57(3):214-218. PubMed ID: 30890290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of sarcopenia in elderly patients undergoing surgery for oral squamous cell carcinoma.
    Madadian MA; Da Costa LS; Kerai A; Bajwa MS; Rogers SN
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):184-190. PubMed ID: 38272707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of cervical lymph node metastases in squamous cell carcinoma of the upper oral cavity - How to manage the neck.
    Doll C; Mrosk F; Wuester J; Runge AS; Neumann F; Rubarth K; Heiland M; Kreutzer K; Voss J; Raguse JD; Koerdt S
    Oral Oncol; 2022 Jul; 130():105898. PubMed ID: 35576886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study.
    Jensen JS; Jakobsen KK; Mirian C; Ghanizada M; Håkansson K; Wessel I; Grønhøj C; Rasmussen JH; von Buchwald C
    Acta Oncol; 2021 Apr; 60(4):491-496. PubMed ID: 33356698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-induced hypothyroidism in patients of oral squamous cell carcinoma: A retrospective analysis of 195 patients.
    Jain PV; Das A; Manikantan K; Sharan R; Mallick I; Chatterjee S; Arun P
    Indian J Cancer; 2022; 59(4):480-484. PubMed ID: 33753621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.
    Liao CT; Lin CY; Fan KH; Wang HM; Ng SH; Lee LY; Hsueh C; Chen IH; Huang SF; Kang CJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):284-90. PubMed ID: 21075550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative propensity for regional metastasis in floor of mouth squamous cell carcinoma versus other oral cavity subsites.
    Wicks C; Zubair F; Ogunbowale A; McMahon J
    Br J Oral Maxillofac Surg; 2022 Nov; 60(9):1276-1278. PubMed ID: 36229310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.